As per the alliance, HORIBA’s full array of instruments and systems for applications ranging from automotive R&D, process and environmental monitoring, in-vitro medical diagnostics, semiconductor manufacturing and metrology, to a broad range of scientific R&D and QC measurements will be available at Particle Sciences.
Particle Sciences, an integrated provider of drug development services, has expertise in micro and nano-particulate drug delivery technologies and drug/device combination products with additional specialized capabilities in topical and mucosal drug products.
Through a range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with development solutions that minimize the time and risk between discovery and the clinic.
Particle Sciences VP of Pharmaceutical Development Robert Lee said the need for particle size analysis and physical characterization in general is growing rapidly within this highly regulated environment and the company is a world leader in particulate formulations and drug/device combination products.
"Particle Sciences is committed to remaining one of the premier drug delivery development services providers. We offer a broad array of drug delivery technologies and routinely work on atypical dosage forms," Lee said.